In the evening of September 18, the National Ethics Committee in Biomedical Research under the Ministry of Health (MoH) approved the clinical trial results of the phase 3 of Nanocovax, a home-grown Covid-19 vaccine.

Korean pharmaceutical firm HLB has signed an MoU with Nanogen, producer of Vietnam's Nanocovax Covid-19 vaccine, to acquire the rights to distribute the vaccine worldwide, except in Vietnam and India, when the vaccine is approved for use.

The Prime Minister has assigned the Ministry of Health to shorten administrative procedures for granting an emergency licence for the locally made Nanocovax vaccine against Covid-19.

Nano Covax is Vietnam’s first COVID-19 vaccine that is entering the third phase of human clinical trial with the participation of 13,000 volunteers. All the volunteers are set to receive two shots by August 15.

Nanogen, a Vietnamese biotechnology and pharmacy firm, has published two scientific articles on the results of research on the Nanocovax vaccine.

At least three provinces, including Binh Duong, Khanh Hoa and Dong Thap, said they want to participate in the trial phase of the locally-made Covid-19 vaccine Nanocovax.

Samples of Covivac, a Vietnamese produced coronavirus vaccine, have been sent to Canada for evaluation of its effectiveness, according to Prof. Dr. Dang Duc Anh, director of the National Institute of Hygiene and Epidemiology (NIHE).

After an emergency meeting, the National Ethics Council agreed to test the locally-made Covid-19 vaccine Nanocovax on 13,000 volunteers. This third phase trial will be completed in mid-August.

The test of locally-made Nanocovax vaccine has yielded positive signs. In case of emergency approval, Vietnam would be able to produce 100 million doses per year.

The clinical trials of Vietnamese COVID-19 vaccine candidate Nano Covax are set to enter Phase 3 this month with the optimal dosage of 25mcg, aiming to further test the safety and efficacy of the vaccine in humans before mass production begins.

Next week, Vietnam will start the phase 3 trial of the Vietnamese-made Nanocovax vaccine on about 13,000 volunteers.

Results of a clinical trial phase 2 of made-in-Vietnam Covid-19 vaccine Nanocovax showed that 100% of vaccinated people made antibodies to fight the virus. The vaccine was also effective on the British variant of the coronavirus.

The time for research and production of Nano Covax, Vietnam’s first candidate vaccine to reach human trial stage, has been shortened as much as possible, but safety has been ensured, said a health official.

The clinical trial of the domestically-made Nanocovax vaccine is going smoothly, and by the end of September, Vietnam will have its first Covid-19 vaccine.

The Hanoi Medical University is to start the initial phase of clinical trials on the second domestically-produced COVID-19 vaccine known as Covivac, developed by the Institute of Vaccines and Medical Biologicals (IVAC) on March 15.

Vietnam has completed the first-dose vaccination of 560 volunteers who participated in the Phase 2 trial of Nanocovax's Covid-19 vaccine, 

While negotiating with foreign vaccine providers, Vietnam will accelerate vaccine purchases to ensure that all people have access to Covid-19 vaccines.

The second phase of the human trials of Nano Covax, a homegrown COVID-19 vaccine, will begin on February 26, following the first phase that has been proven safe.

Vietnam has completed the first phase of the human trials of Nano Covax, a homegrown COVID-19 vaccine, with the participation of 60 volunteers, the Vietnam Military Medical University said on February 8.